What stock will Sohn’s top picker choose next?

On November 18, Griffin – with $4.7bn under management at Munro Partners – heads to Hobart for this year’s face-to-face pitch to investors on his 2023 pick.
Nick Griffin is the chief investment officer of Munro Partners. Picture: Aaron Francis

What stock will Sohn’s top picker choose next?

October 4, 2022
On November 18, Griffin – with $4.7bn under management at Munro Partners – heads to Hobart for this year’s face-to-face pitch to investors on his 2023 pick.
Read Transcript

Nick Griffin is on track to take out the coveted best stock pick at the Sohn Heart & Minds conference.

It has been a year when most picks were hi-tech stocks that took a hiding. “Tech is yesterday’s story for now – although not necessarily forever,” says Griffin, chief investment officer of growth fund manager Munro Partners.

Last year he pitched Onsemi, previously called ON Semiconductor. “We are one of the few who are up for the year, in fact the only one at this point in time. We are on track for a 15-25 per cent ­return,” he says.

Griffin notes that semiconductors have also fallen this year, being horribly cyclical, but Onsemi has gone up. “Even though it is a semiconductor, it’s not really a technology idea, it’s very much an industrial play on decarbonisation,” he says. “We think that is the next big mega trend.”

Onsemi sells power semiconductors that are critical to converting battery power into electricity. Griffin says the shift in electric-vehicle penetration caused an inflection in demand for power semis. This year, Onsemi has had a series of earnings upgrades, all confirming his investment philosophy.

“We are stock pickers. Most fund managers will try and do the macro, be over or underweight certain sectors, or certain bonds or countries. We think that is a total waste of time,” Griffin says. “The reality is equity markets are made up of very few great companies that grow structurally over a long period of time.

“If you can find a good S curve of adoption, be it smartphones, e-commerce, or digital payments, then that S curve will outrun whatever the economy does in the background. That’s what gives us these double-digit returns for six years at Munro and 10 years prior to that. Over the years that’s been Amazon in e-commerce, Salesforce or ServiceNow in enterprise software, ASML in semiconductors and now we think decarbonisation is the next big structural trend.”

On November 18, Griffin – with $4.7bn under management at Munro Partners – heads to Hobart for this year’s face-to-face pitch to investors on his 2023 pick.

The conference – with a twist – was set up by financiers Matthew Grounds, Guy Fowler and Gary Weiss in 2016. They also built an ASX-listed fund that takes stock picks pitched at the conference. All management fees are donated to medical research.

Munro has three separate ­equity growth funds. Each fund is also quoted as managed ETFs on the stock exchange, allowing retail investors access to potential S-curve opportunities outside Australia, from Netflix to decarbonisation. The Global Growth Fund is an absolute return fund, similar to a Platinum or Antipodes, although these are value funds. Munro is about growth in revenue and earnings – as Griffin describes them, the glass-half-full guys in global equities.

A second fund is global growth equities, but only for long positions and without downside protection tools.

The third is the Climate Change Leaders Fund launched in October last year. Griffin says the fund is not an ESG product, but a thematic fund that can be scaled up. “It’s no different to back in 2005, when everyone was launching tech funds or international brand funds,” he says.

Some $50 trillion is to be spent decarbonising the planet on renewable energy, EVs, and energy efficiency. But energy transition is where Griffith sees some of the best plays.

“Think about the European gas situation. LNG is a clear transition fuel required to fill the gap and most of what will fill the gap in India and China as they come off coal. Gas is classic transition fuel that is being treated like a fossil fuel but it is not,” he says.

Munro is backing Texas-based Cheniere Energy. It is not a traditional gas extractor and producer like Woodside. Instead, it builds terminals on the Gulf of Mexico coast, buys the gas off the grid, turns it into LNG and sells it.

“It has gone from nothing 10 years ago to being the world’s second-largest LNG producer today behind Qatar and we’d expect it to be largest at some point. Cheniere is a transition company,” Griffin says.

Rising rates and fears of recession has inevitably checked Munro’s high-growth strategy. “It’s harder and harder to find those situations when you go into a macro slowdown,” Griffin says. Munro’s funds are down about 15 per cent on a one-year rolling basis, which he sees as fair in terms of the market, but quite good compared to Munro’s growth peers, most of which he says are down 40 or 50 per cent.

All year, the firm has been more defensive with higher cash levels and some short selling on the global growth product.

Last year, Munro off-loaded Spotify, Hello Fresh, Square, The Trade Desk, Atlassian and Uber, favouring big cap companies such as Microsoft and Visa for growth through the cycle or healthcare companies like Thermo Fisher and Danaher.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Nick Griffin is on track to take out the coveted best stock pick at the Sohn Heart & Minds conference.

It has been a year when most picks were hi-tech stocks that took a hiding. “Tech is yesterday’s story for now – although not necessarily forever,” says Griffin, chief investment officer of growth fund manager Munro Partners.

Last year he pitched Onsemi, previously called ON Semiconductor. “We are one of the few who are up for the year, in fact the only one at this point in time. We are on track for a 15-25 per cent ­return,” he says.

Griffin notes that semiconductors have also fallen this year, being horribly cyclical, but Onsemi has gone up. “Even though it is a semiconductor, it’s not really a technology idea, it’s very much an industrial play on decarbonisation,” he says. “We think that is the next big mega trend.”

Onsemi sells power semiconductors that are critical to converting battery power into electricity. Griffin says the shift in electric-vehicle penetration caused an inflection in demand for power semis. This year, Onsemi has had a series of earnings upgrades, all confirming his investment philosophy.

“We are stock pickers. Most fund managers will try and do the macro, be over or underweight certain sectors, or certain bonds or countries. We think that is a total waste of time,” Griffin says. “The reality is equity markets are made up of very few great companies that grow structurally over a long period of time.

“If you can find a good S curve of adoption, be it smartphones, e-commerce, or digital payments, then that S curve will outrun whatever the economy does in the background. That’s what gives us these double-digit returns for six years at Munro and 10 years prior to that. Over the years that’s been Amazon in e-commerce, Salesforce or ServiceNow in enterprise software, ASML in semiconductors and now we think decarbonisation is the next big structural trend.”

On November 18, Griffin – with $4.7bn under management at Munro Partners – heads to Hobart for this year’s face-to-face pitch to investors on his 2023 pick.

The conference – with a twist – was set up by financiers Matthew Grounds, Guy Fowler and Gary Weiss in 2016. They also built an ASX-listed fund that takes stock picks pitched at the conference. All management fees are donated to medical research.

Munro has three separate ­equity growth funds. Each fund is also quoted as managed ETFs on the stock exchange, allowing retail investors access to potential S-curve opportunities outside Australia, from Netflix to decarbonisation. The Global Growth Fund is an absolute return fund, similar to a Platinum or Antipodes, although these are value funds. Munro is about growth in revenue and earnings – as Griffin describes them, the glass-half-full guys in global equities.

A second fund is global growth equities, but only for long positions and without downside protection tools.

The third is the Climate Change Leaders Fund launched in October last year. Griffin says the fund is not an ESG product, but a thematic fund that can be scaled up. “It’s no different to back in 2005, when everyone was launching tech funds or international brand funds,” he says.

Some $50 trillion is to be spent decarbonising the planet on renewable energy, EVs, and energy efficiency. But energy transition is where Griffith sees some of the best plays.

“Think about the European gas situation. LNG is a clear transition fuel required to fill the gap and most of what will fill the gap in India and China as they come off coal. Gas is classic transition fuel that is being treated like a fossil fuel but it is not,” he says.

Munro is backing Texas-based Cheniere Energy. It is not a traditional gas extractor and producer like Woodside. Instead, it builds terminals on the Gulf of Mexico coast, buys the gas off the grid, turns it into LNG and sells it.

“It has gone from nothing 10 years ago to being the world’s second-largest LNG producer today behind Qatar and we’d expect it to be largest at some point. Cheniere is a transition company,” Griffin says.

Rising rates and fears of recession has inevitably checked Munro’s high-growth strategy. “It’s harder and harder to find those situations when you go into a macro slowdown,” Griffin says. Munro’s funds are down about 15 per cent on a one-year rolling basis, which he sees as fair in terms of the market, but quite good compared to Munro’s growth peers, most of which he says are down 40 or 50 per cent.

All year, the firm has been more defensive with higher cash levels and some short selling on the global growth product.

Last year, Munro off-loaded Spotify, Hello Fresh, Square, The Trade Desk, Atlassian and Uber, favouring big cap companies such as Microsoft and Visa for growth through the cycle or healthcare companies like Thermo Fisher and Danaher.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Oct 04, 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/Bloomberg
November 9, 2024

Galaxy Digital CEO Mike Novogratz believes bitcoin will hit $US100k

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for cryptocurrency, says US billionaire Mike Novogratz.

Read More
Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍
November 6, 2024

Why this New York hedge fund manager sees opportunity in European stocks

Influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick.

Read More
Vihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie Douvis
November 5, 2024

Antipodes’ Ross says short-term wealth hinges on US election

The portfolio manager says defensive stocks pose a bigger risk than the magnificent seven for investors that are overexposed to the American sharemarket.

Read More
Antipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John Feder
November 5, 2024

Concentration risk key for investors: Antipodes Partners’ Vihari Ross

The concentration risk in global stock indexes that has built up during the strong rise over the past year must now be a key consideration for global investors, according to Vihari Ross.

Read More
JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.
November 5, 2024

The fundie betting big on China – with help from AI

Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders.

Read More
Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.
October 29, 2024

Why this fundie wants you to ‘wince’ at his stock picks

When fund managers come to pitch their favourite stock at the annual Sohn Hearts & Minds conference, there are two ways they can go: they can play it safe, or they can take a risk and shock the room.

Read More
October 27, 2024

IFM Investors’ Rikki Bannan backs small cap investments to rebound after mixed performance

IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks.

Read More
October 22, 2024

Meet the 2024 Conference Managers

Following a global search, the Conference Fund Manager Selection Committee is pleased to share eleven new managers for 2024.

Read More
October 21, 2024

Chris Kourtis is on a winning streak. Here’s his next ASX pick

Chris Kourtis of Ellerston Capital thinks he’s found another winner and thinks it’s the last chance to have a bite at the cherry before the strategy plays out.

Read More
Ellerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta Campion
October 21, 2024

Why Ellerston Capital’s Chris Kourtis plans to back a ‘hated’ stock

Chris Kourtis of Ellerston Capital plans to tip one of the “most hated” stocks in Australia when he presents at the 2024 Sohn Hearts & Minds Conference.

Read More
 ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion
October 14, 2024

Alex Pollak champions rewards of disruptive investment

Alex Pollak’s funds management company Loftus Peak rode the Nvidia wave and he is now looking at more opportunities in disruptive industry stocks.

Read More
October 8, 2024

Sumit Gautam - Why AI won't deliver in 2025 | Scalar Gauge

Sumit Gautam is the Founder of Scalar Gauge and speaks with Equity Mates ahead of his appearance at the Sohn Hearts & Minds conference.

Read More
September 30, 2024

Missed out on Nvidia and Ozempic? This fundie says it’s never too late

Northcape Capital’s Fleur Wright is still kicking herself for not owning market darlings Nvidia and Novo Nordisk, the maker of the weight loss wonder drug Ozempic, before shares of those companies rocketed in 2023.

Read More
September 23, 2024

Scalar Gauge Fund founder Sumit Gautam cautious about over-hyped AI

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype.

Read More
September 9, 2024

The Wellcome Trust’s Nick Moakes made a 100-year bet. It’s paying off

Chief Investment Officer, Nick Moakes raised almost $3 billion at ultra-low rates. Sometimes the long view can be the most profitable.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.